United States of America, from 3 January 2020 to 6:23pm CEST, 21 June 2021, there have been 33,190,195 confirmed cases of COVID-19 with
Patients Under Investigation (PUI) in the United States
CDC in the early stages released information regarding the number of cases and people under investigation that was updated regularly on Mondays, Wednesdays, and Fridays. Below we provide the historical reports that we were able to gather in order to track the progression in the number of suspected cases and US states involved through time in the initial stages
Timeline of Events
On January 31, HHS declared Coronavirus a Public Health Emergency in the US As of Jan. 31, the Wuhan coronavirus is officially a public health emergency in the United States, Alex Azar, secretary of the US Department of Health and Human Services (HHS), announced at a White House press briefing.
On Jan. 31, the U.S. Centers for Disease Control and Prevention (CDC) issued a federal quarantine for 14 days affecting the 195 American evacuees from Wuhan, China. Starting Sunday, Feb. 2, U.S. citizens, permanent residents and immediate family who have visited China's Hubei province will undergo a mandatory 14 days quarantine and, if they have visited other parts of China, they would be screened at airports and asked to self-quarantine for 14 days. The last time the CDC had issued a quarantine was over 50 years ago in the 1960s, for smallpox.
President Donald Trump signed an order on Jan. 31 for the U.S. to deny entry to foreign nationals who traveled to China within the preceding two weeks, aside from the immediate family of U.S. citizens.
On Jan. 30, the CDC had confirmed the first case of person to person transmission in the U.S.:  the husband of the Chicago, Illinois case who had returned from Wuhan, China on Jan. 13 and who tested positive for the virus on Jan. 24).
CDC stated on Jan. 30 that "It is likely there will be more cases of 2019-nCoV reported in the U.S. in the coming days and weeks, including more person-to-person spread."
The virus had been confirmed in 5 states.
On Jan. 31, New York City health officials vehemently denied the rumor regarding a coronavirus case in the city .. On Feb. 1, however, the city's health commissioner did report that there was a test being performed on a person under 40 who had returned from China, developed matching symptoms, and tested negative to the seasonal flu.
Most US patients had recently visited Wuhan.
All of the first five U.S. cases were described as mild.
A study on the first US case of novel coronavirus detailed mild symptoms followed by pneumonia
U.S. Airlines suspended ALL flights between the U.S. and China
On Friday, January 31, Delta, American and United announced they would temporarily suspend all of their mainland China flights in response to the coronavirus outbreak.
Prior to this January 31 announcement:
UNITED AIRLINES on Jan. 28 had announced it would cut 24 flights between the U.S. and China for the first week of February.
AMERICAN AIRLINES on Jan. 29 had announced it would suspend flights from Los Angeles to Shanghai and Beijing from Feb. 9 through March 27, 2020. It will maintain its flight schedules (10 daily A/R) from Dallas-Fort Worth to Shanghai and Beijing, as well as from Los Angeles and Dallas-Fort Worth to Hong Kong.
DELTA had not adjusted its schedule of direct flights from the U.S. to China. It is the only airline with direct flights to not take action so far.
The White House was considering issuing a ban on flights between the United States and China, as of late Jan. 28. Italy has announced on January 31 that it was suspending all flights to and from China following the first 2 cases of coronavirus in Italy.
Travel Alert: Do Not Travel to China
Previously, on January 29, the advisory was set at a lower "Level 3: Reconsider Travel" advising not to travel to Hubei Province: (Level 4) and reconsider travel to the remainder of China (Level 3).
The CDC on Jan. 28 issued a Level 3 Warning, recommending that travelers avoid all nonessential travel to China .
Screening incoming passengers at 20 airports in the U.S.
On January 17, the CDC announced that 3 airports in the United States would begin screening incoming passengers from China: SFO, JFK, and LAX  Other 2 airports were added subsequently, and on January 28, the U.S. Department of Health and Human Services (HHS) announced that 15 additional U.S. airports (bringing the total to 20) would begin screening incoming travelers from China.
Below is the complete list of airports where screening for the 2019 Novel Coronavirus (2019-nCoV) is in place:
Los Angeles International (LAX)
San Francisco International (SFO)
New York JFK
Atlanta Hartsfield-Jackson International
Houston George Bush Intercontinental
Dallas-Fort Worth International
San Diego International
Anchorage Ted Stevens International
Minneapolis-St. Paul International
Washington Dulles International
Newark Liberty International
Boston Logan International
El Paso International
Puerto Rico's San Juan Airport
Sources for the historical account
Novel Coronavirus (2019-nCoV) situation reports - World Health Organization (WHO)
2019 Novel Coronavirus (2019-nCoV) in the U.S -. U.S. Centers for Disease Control and Prevention (CDC)
Symptoms of Novel Coronavirus (2019-nCoV) - CDC
China Travel Advisory - U.S. State Department, accessed January 31, 2020.
Novel Coronavirus in China - Warning - Level 3, Avoid Nonessential Travel - CDC, January 28, 2020.
Public Health Screening to Begin at 3 U.S. Airports for 2019 Novel Coronavirus (“2019-nCoV”) - CDC January 17, 2020
First Travel-related Case of 2019 Novel Coronavirus Detected in United States - CDC, January 21, 2020
Second Travel-related Case of 2019 Novel Coronavirus Detected in United States - CDC, January 24, 2020
CDC confirms additional cases of 2019 Novel Coronavirus in United States - CDC, January 26, 2020
2019 Novel Coronavirus (2019-nCoV) in the U.S. - CDC, Updated January 29, 2020
White House considers ban on flights to China amid coronavirus outbreak - USA Today, Jan. 28, 2020
CDC Confirms Person-to-Person Spread of New Coronavirus in the United States - CDC Press Release, Jan. 30, 2020
NYC Officials Deny Report Of Coronavirus Amid Confusion - Forbes, Jan. 31, 2020
Delta, American, United to suspend all China mainland flights as coronavirus crisis grows - USA Today, Jan. 31, 2020
Secretary Azar Declares Public Health Emergency for United States for 2019 Novel Coronavirus - U.S. Department of Health and Human Services (HHS), Jan. 31, 2020
Man returning from Wuhan, China is first case of 2019 Novel Coronavirus confirmed in Massachusetts - Massachusetts Department of Public Health, Feb. 1, 2020
County of Santa Clara Public Health Department Reports First Case of Novel (new) Coronavirus - Santa Clara County Public Health, Jan. 31, 2020
Coronavirus: First case confirmed in Santa Clara County - Mercury News, Jan. 31. 2020
Coronavirus (COVID-19) in the U.S. - Statistics & Facts Published by John Elflein, Jun 21, 2021 COVID-19, short for the coronavirus disease 2019, has spread to almost every country and territory around the world, infecting millions of people and devastating the global economy. As of June 16, 2021, the number of COVID-19 cases worldwide had reached over 179 million. In addition, the number of deaths from COVID-19 was almost 3.9 million. The United States is the country with the highest number of confirmed cases and deaths. The U.S. government’s overall response to the pandemic has been criticized, and state governments have also come under fire for enforcing rules that were not tough enough and lifting restrictions too early. However, the country’s vaccination rollout has so far been a success, with the U.S. leading the world in total number of vaccinations administered. Nevertheless, experts continue to warn against complacency and stress the importance of following guidelines and remaining vigilant to avoid another rise in new cases. This is particularly important considering the increasing number of cases caused by new COVID-19 variants that can spread more easily and cause more severe illness. Read more
STATISTICS ON THE TOPIC
Cases and deaths by state
Public awareness and concern
NUMBER OF COVID-19 CASES IN THE U.S. AS OF JUNE 21, 2021 (IN MILLIONS) 34.4mNUMBER OF DEATHS DUE TO COVID-19 IN THE U.S. AS OF JUNE 21, 2021 617,166TOTAL NUMBER OF CASES OF COVID-19 IN THE REGION OF THE AMERICAS AS OF JUNE 18, 2021 (IN MILLIONS) 70.3m
Infection rates of viruses that caused major outbreaks worldwide as of 2020
Fatality rate of major virus outbreaks in the last 50 years as of 2020
Coronavirus (COVID-19) cases, recoveries, and deaths worldwide as of June 21, 2021
COVID-19 cases, recoveries, deaths in most impacted countries as of June 21, 2021
Distribution of coronavirus (COVID-19) cases worldwide as of June 16, 2021
COVID-19 cases worldwide as of June 21, 2021, by country
COVID-19 deaths worldwide as of June 21, 2021, by country
Total number of U.S. coronavirus (COVID-19) cases and deaths as of June 20, 2021
Number of U.S. coronavirus (COVID-19) cases from Jan. 20, 2020-June 18, 2021, by day
Cumulative cases of COVID-19 in the U.S. from Jan. 20, 2020 to June 18, 2021, by day
Distribution of U.S. coronavirus (COVID-19) cases as of June 15, 2021, by ethnicity
COVID-19 projected new U.S. cases per day from Dec. 1 to Mar. 31, 2021, by scenario
COVID-19, pneumonia, and influenza deaths reported in the U.S. June 15, 2021
Coronavirus (COVID-19) deaths per day compared to all causes U.S. 2021
COVID-19 deaths reported in the U.S. as of June 9, 2021, by place of death
Number of coronavirus (COVID-19) deaths in the U.S. as of March 2, 2021, by race
Coronavirus (COVID-19) death rate in the U.S. as of March 2, 2021, by race
Distribution of COVID-19 deaths in the U.S. as of June 9, 2021, by race
Projected COVID-19 deaths in the U.S. from Dec. 1, 2020 to Mar. 31, 2021, by scenario
Cases and deaths by state
Number of COVID-19 tests conducted in the U.S. as of April 6, 2021, by state
Total number of U.S. coronavirus (COVID-19) cases as of June 21, 2021, by state
Rate of U.S. coronavirus (COVID-19) cases as of June 21, 2021, by state
Number of COVID-19 deaths in the United States as of June 21, 2021, by state
COVID-19 death rates in the United States as of June 21, 2021, by state
COVID-19 vaccine doses distributed and administered in the U.S. as of June 2021
Number of COVID-19 vaccine doses distributed in the U.S., Jan. 25, 2021, by state
Number of COVID-19 vaccine doses administered in the U.S., June 20, 2021, by state
COVID-19 vaccinations administered in the U.S. as of June 20, 2021, by manufacturer
U.S. opinions on when a COVID-19 vaccine will be available as of March 11, 2020
U.S. adults who would get a coronavirus vaccine, Jan. 2020 to Jan. 2021
COVID-19 vaccination willingness among U.S. adults in September and December 2020
U.S. adults who are COVID-19 vaccine hesitant as of Dec. 2020, by group
Reasons for COVID-19 vaccine hesitancy among U.S. adults as of December 2020
Public awareness and concern
U.S. adults' level of concern about the COVID-19 outbreak from Jan. to Oct. 2020
U.S. opinion on the health risk severity of COVID-19 in the U.S., Jan. 2021, by age
Share of U.S. respondents who agree with shelter-in-place measures, as April 20, 2020
Opinions on people who choose not to use a face mask during COVID pandemic, June 2020
Opinion of U.S. adults on predicted fatalities due to COVID-19 as of March 11, 2020
U.S. adults' approval of the Trump administration's handling of COVID-19 2021
Satisfaction with the government's response to the COVID-19 pandemic 2020
COVID-19 pandemic's level of impact on personal finances in selected countries 2020
U.S. unemployment rate: seasonally adjusted May 2021
Increase in Fed balance sheet due to QE during COVID-19 2021
Forecasted change in GDP due to COVID-19, by country and scenario 2020
Global change in travel and tourism revenue due to COVID-19 by country 2019-2020
COVID-19's effect on hotel KPIs in the U.S. as of March 13, 2021
Daily year-on-year impact of COVID-19 on U.S. restaurant dining 2020-2021
U.S. monthly retail sales development during COVID-19 outbreak 2020-2021, by sector
Coronavirus: U.S. year-over-year monthly retail sales comparison, by sector 2019-2021
Rt of COVID-19 in the U.S. as of January 23, 2021, by state
Rate of COVID-19 hospitalizations in the U.S. as of June 5, 2021, by ethnicity
U.S. adults with medical care delayed or avoided due to COVID-19 June 2020, by age
U.S. adults who reported depressive symptoms from Apr. 2020-June 2021, by gender
U.S. adults with anxiety disorder symptoms from Apr. 2020-June 2021, by gender
U.S. Leadership in Global Health
The United States is committed to leading the global response to the COVID-19 pandemic. We have reengaged the WHO; committed to researching, developing, and supporting global distribution of safe and effective vaccines, diagnostics, and therapeutics; and engaged international partners to facilitate expanded international manufacturing of vaccines.
Stopping COVID-19 is the Biden-Harris Administration’s number one priority. ANTONY J. BLINKEN SECRETARY OF STATE
As President Biden has made clear, the United States supports multilateral approaches and will work as a partner to address global challenges. It is a Biden-Harris Administration priority to combat this pandemic and to help America and the global community build back better prepared to prevent, detect, and respond to public health threats.
None of us face this threat alone, which is why the United States—through USAID—is leading the world as the largest single donor to Gavi, the vaccine alliance, in support of COVAX. The U.S. government made an initial $2 billion contribution to Gavi in March 2021 and plans to contribute an additional $2 billion to Gavi through 2022. On April 15, 2021, the United States co-hosted with Gavi the “One World Protected” virtual pledge event, which raised nearly $400 million in new commitments in support of the COVAX Advance Market Commitment. These new resources will support additional procurement and equitable distribution of WHO-authorized, safe and effective vaccines to low and middle-income countries.
Additionally, under the American Rescue Plan Act of 2021, the U.S. government is spending nearly $11 billion in foreign assistance to fight COVID-19, address secondary impacts of the pandemic, and strengthen the global health security architecture.
Since the onset of the pandemic, the technical expertise, critical infrastructure, and whole-of-government approach created through Global Health Security Agenda (GHSA) partnerships have bolstered preparedness to rapidly respond to COVID-19 in partner countries.
DISCOVER MORE U.S. LEADERSHIP BOLSTERS GLOBAL FIGHT AGAINST COVID-19 BIDEN PRIORITIZES U.S. SUPPORT FOR GLOBAL COVID-19 RESPONSE U.S. RALLIES SUPPORT FOR GLOBAL VACCINE DISTRIBUTION U.S. SHIPS COVID-19 VACCINES TO PACIFIC ISLAND NATIONS
Multilateral Approach to Beating the Pandemic
As President Biden has made clear, the United States supports multilateral approaches and will work as a partner to address global challenges. This is a global challenge that requires a global response.
Through the UK-led G7, we will join forces to beat COVID-19 and build back better. Drawing on our strengths and values as democratic and open economies and societies, we will work together and with others to make 2021 a turning point and to shape a recovery that promotes the health and prosperity of our people and planet.
In working to strengthen the WHO and support its leading and coordinating role, we will:
accelerate global vaccine development and deployment;
work with industry to increase manufacturing capacity, including through voluntary licensing;
improve information, data, and sample sharing, including sequencing new variants;
promote transparent and responsible practices; and
bolster vaccine confidence.
We reaffirm our support for all pillars of the Access to COVID-19 Tools Accelerator (ACT-A), its COVAX facility, and affordable and equitable global access to vaccines, therapeutics, and diagnostics.
Italy and The European Commission will cohost a G-20 Global Health Summit on May 21. The Summit is an opportunity for G20 and invited leaders, heads of international and regional organizations, and representatives of global health bodies to share lessons learned from the COVID-19 pandemic and develop and endorse a ‘Rome Declaration’ of principles to guide future action. The Summit will build on other health initiatives and processes, including those taking place in the G7.
DISCOVER MORE U.S. SUPPORTS GLOBAL COVID-19 RESPONSE EFFORTS U.S.-BELGIUM PARTNERSHIP IS ON FRONT LINES OF COVID-19 VACCINE DISTRIBUTION BIDEN: QUAD PARTNERS BOOSTING COVID-19 VACCINE PRODUCTION IN INDIA
Safe and Effective Vaccines
Getting vaccinated will help keep you, your family, and your community healthy and safe. Vaccines will help bring this pandemic to an end, let us resume our normal lives, and reopen the economy.
The United States and our partners adhere to internationally accepted scientific standards for stringency and transparency in clinical trials, which are critical for maintaining public trust in the safety and efficacy of vaccines.
The U.S. government continues to monitor vaccine safety and efficacy even after vaccines are authorized for use by our Food and Drug Administration. We encourage the World Health Organization (WHO) and all foreign governments to rigorously assess all vaccines for safety, efficacy, and good manufacturing practices before, during, and after deployment.
U.S. COVID-19 Response: Strengthening Global Supply Chains
President Biden is determined to help the global health system build back better. The United States is committed to working with partners in the private sector and with foreign governments to strengthen a diversified and resilient global supply chain, improve key global manufacturing capacities, and close global gaps in the availability and distribution of vaccines, therapeutics, testing, and PPE.
Much of this work is guided by a series of Executive Orders and National Security Memorandum 1, released in the opening weeks of the Biden-Harris Administration, to provide U.S. leadership on global health and security.
Long-term Global Health Security Infrastructure Improvement and Reforms
Advancing global health security and disease outbreak preparedness is vital not only to protect health and safety, but also to ensure economic prosperity and defend national security interests. As we have seen, when people become sick from an infectious disease, the cost can be measured in lives and suffering, but also in impacts to people’s livelihoods and economic security.
We are committed to strengthening global health security so that the world may build back better in order to prevent, detect, and respond to the next infectious disease outbreak.
As a founding member of the Global Health Security Agenda (GHSA) in 2014, the United States has invested in training and programs to strengthen countries’ public health infrastructure.
Our commitment to global health builds on a long tradition. Over the past two decades, the United States has provided more than $140 billion in global health assistance. We are the world’s largest contributor to global health and the international response to COVID-19. Our assistance also addresses the humanitarian, economic, and social impacts of COVID-19.
Longstanding health partnerships and investments—including through the Global Health Security Agenda, President’s Malaria Initiative, the President’s Emergency Plan for AIDS Relief (PEPFAR), and Gavi, the Vaccine Alliance (Gavi)—have provided the technical assistance to support broader country readiness and vaccine service delivery needed to bolster preparedness, rapidly respond to COVID-19, and save lives.
We are also evaluating mechanisms that will leverage the current international political will to meaningfully and urgently improve global health security infrastructure to prevent, detect, and respond to future public health threats to include:
strengthening the WHO;
improving International Health Regulations implementation; and
engaging with international partners and the private sector to distribute vaccines and determine appropriate approaches for safe travel and trade.
DEPARTMENT RESOURCES Democracy, Human Rights, and Labor COVID-19, Democracy, Good Governance, and Human Rights Educational and Cultural Affairs Exchange Visitor Program Information on Coronavirus (COVID-19) Family Liaison Office COVID-19: FLO Crisis Management Resources Foreign Service Institute FSI Training Status Resources for Resilience During COVID-19 from the Foreign Service Institute Short-Term Housing Options from the Foreign Service Institute Office of Foreign Missions Office of Foreign Missions: Coronavirus Disease 2019 (COVID-19) Information and Resources Office of Global Partnerships Office of Global Partnerships: Coronavirus Disease 2019 (COVID-19) Information and Resources President’s Emergency Plan for AIDS Relief (PEPFAR) PEPFAR’s HIV Response in the Context of Coronavirus Disease 2019 (COVID-19) Small and Disadvantaged Business Utilization COVID-19 Resources for Government Contractors Under Secretary for Management Department of State COVID-19 Workplace Safety Plan